FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称RETAVIBART
异名/同义词H-GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-457) (VH (HOMO SAPIENS IGHV5-51*01 (86.7%) -(IGHD) -IGHJ2*01 (93.8%), CDR-IMGT (8.8.20) (26-33.51-58.97-116)) (1-127) -HOMO SAPIENS IGHG1*03, G1M3, NG1M1 CH1 R120, CH3 E12, M14, 9-G1V24 CH3 L107, S114 (CH1 R120 (224) (128-225), HINGE 1-15 (226-240), CH2 (241-350), CH3 E12 (366), M14 (368), M107>L (438), N114>S (444) (351-455), CHS (456-457)) (128-457)), (230-215')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HOMO SAPIENS (1'-215') (V-KAPPA (HOMO SAPIENS IGKV3-15*01 (92.6%) -IGKJ5*01 (91.7%) I126>N (107'), CDR-IMGT (6.3.10) (27'-32'.50'-52'.89'-98'))(1'-108') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (154'), V101 (192')) (109'-215')); DIMER (236-236'':239-239'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA
IMMUNOGLOBULIN G1 (438-LEUCINE,444-SERINE), ANTI-(RESPIRATORY SYNCYTIAL VIRUS PRE-FUSION F PROTEIN) (HUMAN MONOCLONAL TNM001 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL TNM001 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) FUSION GLYCOPROTEIN F), HOMO SAPIENS MONOCLONAL ANTIBODY (RETAVIBART)
RETAVIBART
RETAVIBART [INN]
TNM001
TNM-001
CAS登记号3023741-03-6
物质唯一标识(Unique Ingredient Identifier)HQ9W597Z73
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System